{"disease":{"id":"atopic-dermatitis-eczema","name":"atopic dermatitis eczema"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03823794","title":"Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)","phase":"","overall_status":"COMPLETED","enrollment_count":148166,"lead_sponsor_name":"Momentum Data","has_results":true},{"nct_id":"NCT05316805","title":"China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03409367","title":"A Community-based Assessment of Skin Care, Allergies, and Eczema","phase":"NA","overall_status":"COMPLETED","enrollment_count":1260,"lead_sponsor_name":"Oregon Health and Science University","has_results":true},{"nct_id":"NCT04804605","title":"Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1220,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT05938478","title":"Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT05330637","title":"Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04773600","title":"Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":683,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT04773587","title":"Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":654,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT04845620","title":"Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":652,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":true},{"nct_id":"NCT04154839","title":"Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong","phase":"","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT03742414","title":"Seal, Stopping Eczema and Allergy Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":398,"lead_sponsor_name":"Kari Nadeau, MD, PhD","has_results":false},{"nct_id":"NCT03871998","title":"Short-term Topical Application to Prevent Atopic Dermatitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"University College Cork","has_results":false},{"nct_id":"NCT03981926","title":"Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT06464133","title":"Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT04760314","title":"A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT07438509","title":"Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":270,"lead_sponsor_name":"Jinnah Postgraduate Medical Centre","has_results":false},{"nct_id":"NCT05642208","title":"Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":256,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03054428","title":"Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT05990725","title":"Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":240,"lead_sponsor_name":"Almirall, S.A.","has_results":false},{"nct_id":"NCT05958407","title":"A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":235,"lead_sponsor_name":"LEO Pharma","has_results":false},{"nct_id":"NCT04017520","title":"Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":221,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT06004986","title":"DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":216,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT07046039","title":"The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.","phase":"","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"King Abdulaziz University","has_results":false},{"nct_id":"NCT06024499","title":"Phase 2 Trial of HY209gel in Atopic Dermatitis Patients","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":210,"lead_sponsor_name":"Shaperon","has_results":false},{"nct_id":"NCT03175354","title":"A Study in Subjects With Moderate Atopic Dermatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":209,"lead_sponsor_name":"Ralexar Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05935085","title":"This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":201,"lead_sponsor_name":"AnaptysBio, Inc.","has_results":false},{"nct_id":"NCT07216027","title":"A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT06353087","title":"Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04500834","title":"Metal Panel Allergen Patch Test Study","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Allerderm","has_results":false},{"nct_id":"NCT05689151","title":"A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.","phase":"","overall_status":"RECRUITING","enrollment_count":183,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT03540043","title":"Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"PurGenesis Technologies Inc.","has_results":false},{"nct_id":"NCT04445298","title":"Skin Barrier Assessment in Pregnancy and at Birth","phase":"","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"National Jewish Health","has_results":false},{"nct_id":"NCT05590585","title":"Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT03235024","title":"Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"AOBiome LLC","has_results":true},{"nct_id":"NCT06636240","title":"Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Taipei Medical University Shuang Ho Hospital","has_results":false},{"nct_id":"NCT06096857","title":"Cardamom and Topical Roseomonas in Atopic Dermatitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05579899","title":"Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Evommune, Inc.","has_results":true},{"nct_id":"NCT06998056","title":"Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":false},{"nct_id":"NCT04156191","title":"Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Arcutis Biotherapeutics, Inc.","has_results":false},{"nct_id":"NCT05790083","title":"Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Bionorica SE","has_results":false},{"nct_id":"NCT07355075","title":"A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Turn Therapeutics","has_results":false},{"nct_id":"NCT06474728","title":"Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT03795506","title":"TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":96,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06268847","title":"Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Abyss Ingredients","has_results":false},{"nct_id":"NCT05382819","title":"A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":89,"lead_sponsor_name":"Fresh Tracks Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06756438","title":"Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.","phase":"NA","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"NAOS Les Laboratoires","has_results":false},{"nct_id":"NCT05583019","title":"Atopic Dermatitis With Accelerometry and Polysomnography (ADAP)","phase":"","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"SymmetryScience Group, Inc.","has_results":false},{"nct_id":"NCT04021862","title":"A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT04085549","title":"Effects of a Berry Oil Cream on Atopic Eczema and Skin","phase":"NA","overall_status":"TERMINATED","enrollment_count":83,"lead_sponsor_name":"Petra Larmo","has_results":false},{"nct_id":"NCT04295824","title":"Skin Pathology Assessment With Optical Technologies","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Sheffield Teaching Hospitals NHS Foundation Trust","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}